Literature DB >> 15987624

Issues with care in the elderly patient presenting with acute ischemia.

S Michael Gharacholou1, Karen P Alexander.   

Abstract

The issues surrounding care of the elderly patient with acute coronary syndromes (ACS) present significant challenges to clinicians and investigators. The elderly often have atypical symptoms of acute ischemia, have greater medical comorbidities, and are more likely to die from ischemic heart disease. Important differences exist among elderly patients with ACS as compared with their younger counterparts, including age-related changes in physiology, metabolism of drugs, and overall functional status, all of which influence treatment patterns and clinical outcomes. Given the absence of elderly patients in many clinical trials, these high-risk individuals are sometimes managed with more conservative strategies, which at times diverge from accepted guidelines. This review addresses clinically important issues in the care of elderly patients with acute ischemia and highlights recent studies that provide new insight into this complex area of cardiovascular care.

Entities:  

Mesh:

Year:  2005        PMID: 15987624     DOI: 10.1007/s11886-005-0048-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  48 in total

1.  Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack study.

Authors:  R J Goldberg; J Yarzebski; D Lessard; J M Gore
Journal:  Arch Intern Med       Date:  2000-11-27

Review 2.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 3.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

4.  Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group.

Authors:  D C Goff; H A Feldman; P G McGovern; R J Goldberg; D G Simons-Morton; C E Cornell; S K Osganian; L S Cooper; J R Hedges
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

7.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes.

Authors:  P Y Lee; K P Alexander; B G Hammill; S K Pasquali; E D Peterson
Journal:  JAMA       Date:  2001-08-08       Impact factor: 56.272

8.  Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4.

Authors:  Eric D Peterson; Charles V Pollack; Matthew T Roe; Lori S Parsons; Katherine A Littrell; John G Canto; Hal V Barron
Journal:  J Am Coll Cardiol       Date:  2003-07-02       Impact factor: 24.094

9.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

Review 10.  Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.

Authors:  Luigi Ferrucci; Jack M Guralnik; Stephanie Studenski; Linda P Fried; Gordon B Cutler; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.